°å³Ø½ñ¡¦°å³Ø»¨»ï¤Î¥ª¥ó¥é¥¤¥ó½ñŹ¡Ã¥á¥Æ¥ª¡¦¥á¥Ç¥£¥«¥ë¥Ö¥Ã¥¯¥»¥ó¥¿¡¼

¥á¥Æ¥ª¡¦¥á¥Ç¥£¥«¥ë¥Ö¥Ã¥¯¥»¥ó¥¿¡¼¡Ã350°Ê¾å¤Î°å³Ø½ÐÈǼҡ¢360¼ï°Ê¾å¤Î»¨»ï¥Ð¥Ã¥¯¥Ê¥ó¥Ð¡¼¤ò¸¡º÷¡¦¹ØÆþ¤Ç¤­¤ë°å³Ø½ñÀìÌç½ñŹ¤Ç¤¹¡£

¸½ºß¤Î¥«¡¼¥È¾õ¶·
¾¦ÉÊÅÀ¿ô¡§0ºý
¹ç·×¶â³Û¡§0±ß
¸½ºßÇ㤤ʪ¥«¡¼¥È¤Ë
¾¦ÉÊ¤ÏÆþ¤Ã¤Æ¤¤¤Þ¤»¤ó
TOP > ½ÐÈǼҰìÍ÷ > ¥¢¥ë¥¿½ÐÈÇ

¥«¥Æ¥´¥ê¡¼¥á¥Ë¥å¡¼


¥á¥Ç¥£¥«¥ë¥Ö¥Ã¥¯¥»¥ó¥¿¡¼½ÐÈǼҤ´ÅÐÏ¿¤Î¤ª´ê¤¤
¥á¥Ç¥£¥«¥ë¥ª¥ó¥é¥¤¥ó
¥á¥Ç¥£¥«¥ë¥ª¥ó¥é¥¤¥ó

¥â¥Ð¥¤¥ë¥µ¥¤¥È

QR¥³¡¼¥É

·ÈÂÓ¤ÇQR¥³¡¼¥É¤òÆÉ¤ß¼è¤ë¤«¡¢¤Þ¤¿¤Ï²¼µ­¤è¤ê·ÈÂÓ¤ËURL¤òÁ÷¿®¤Ç¤­¤Þ¤¹¡£



RSS¥Õ¥£¡¼¥É

RSS¥ê¡¼¥À¡¼ÅÐÏ¿¤Ç¤â¤Ã¤ÈÊØÍø¤Ë

½ÐÈǼҡ§¥¢¥ë¥¿½ÐÈÇ
½ÐÈǼҰìÍ÷¤ØÌá¤ë
              
41·ïÃæ 1¡Á10·ïÌܤòɽ¼¨

¥Á¥§¥Ã¥¯¤·¤¿¾¦Éʤ¬¤¢¤ë¾ì¹ç¤Ï¼¡¤Î²èÌ̤ذܤëÁ°¤Ë¡¢¥«¡¼¥È¤Ëɬ¤ºÆþ¤ì¤Æ¤¯¤À¤µ¤¤¡£
¥Á¥§¥Ã¥¯¤·¤¿¾¦Éʤò¥«¡¼¥È¤ËÆþ¤ì¤ë

Parkinson's disease 2011

 
4,200±ß¡ÊÀǹþ¡Ë
½ÐÈǼҡ§¥¢¥ë¥¿½ÐÈÇ Ãø¼Ô¡§»³Ëܸ÷Íø(ÊÔ)

¹ñÆâ³°¤Î¥Ñ¡¼¥­¥ó¥½¥óɼ£ÎŤ˷Ȥï¤ëÎ×¾²°å¤ä¸¦µæ¼Ô¤¬°ìƱ¤Ë²ñ¤·¤Æ¤½¤ÎºÇÀèü¤Î¼£ÎŤΤ¢¤êÊý¤Ë¤Ä¤¤¤ÆÆ¤µÄ¤¹¤ë¡ÖInternational Expert Meeting on the Treatment of Parkinson's Disease¡ÊIEPD¡Ë¡×¡£Ëܽñ¤Ï¡¤¤½¤ÎÂè5²ó¹Ö±é¤ò¤Þ¤È¤á¤¿¤â¤Î¤Ç¡¤9¤Î±éÂê¤ò¼ýºÜ¤·¤Æ¤¤¤Þ¤¹¡£

¤ª¼è¤ê´ó¤»(5¡Á10±Ä¶ÈÆü¤ÇȯÁ÷)

Bipolar Disorder¡¡9

 
2,940±ß¡ÊÀǹþ¡Ë
½ÐÈǼҡ§¥¢¥ë¥¿½ÐÈÇ Ãø¼Ô¡§Bipolar Disorder¸¦µæ²ñ(ÊÔ)

Bipolar Disorder¸¦µæ²ñ¤ÎÂè9²ó¹Ö±é¤ò¤Þ¤È¤á¤¿¤â¤Î¤Ç¡¤°ìÈ̱éÂê10Âê¤È¥·¥ó¥Ý¥¸¥¦¥à¹Ö±é2Âê¤ò¼ýºÜ¡£

¤ª¼è¤ê´ó¤»(5¡Á10±Ä¶ÈÆü¤ÇȯÁ÷)
½ÐÈǼҡ§¥¢¥ë¥¿½ÐÈÇ Ãø¼Ô¡§David Taylor Carol Paton Shitij Kapur(Ãø) ÆâÅÄ͵Ƿ ÎëÌÚ·òʸ ÅÏî´¹Õ°ìϺ (´ÆÌõ)

Ëܽñ¤Ï±Ñ¹ñ¤òÂåɽ¤¹¤ëÀº¿À²Ê°åÎŵ¡´Ø¥â¡¼¥º¥ì¥¤¤¬ºîÀ®¤·¤¿½èÊý¥¬¥¤¥É¥é¥¤¥ó¡ÖMaudsley Prescribing Guidelines¡¡10th edition¡×¤ÎË®Ìõ¤Ç¤¢¤ê¡¢½èÊý°å¤Ë¤È¤Ã¤Æ¤Î¥Ï¥ó¥É¥Ö¥Ã¥¯¤È¤·¤ÆÈ¯Å¸¤·¤Æ¤­¤¿¤³¤Î¥¬¥¤¥É¥é¥¤¥ó¤Ï¡¢Æü¾ïÁø¶ø¤¹¤ëÎ×¾²¾ìÌ̤ˤª¤±¤ë¸þÀº¿ÀÌô¤Î½èÊý¤Ë¤ª¤¤¤Æ¶Ë¤á¤Æ¼ÂÁ©Åª¤ÇÍ­ÍѤʤâ¤Î¤Ç¤¢¤ë¡£º£²ó¤ÎÂè10ÈǤϡ¢Shitij Kapur»á¤¬¿·¤¿¤Ë²Ã¤ï¤Ã¤ÆºîÀ®¤µ¤ì¤¿¤â¤Î¤Ç¡¢¿´Ë¼ºÙư¤Ë¤ª¤±¤ë¸þÀº¿ÀÌô¤Î»ÈÍÑ¡¢¹³¤¦¤ÄÌô¤ÎÂåÂØ¤È¤Ê¤ëÌôºÞ¡¢ÈëÌ©ÅêÌôÅù¤ÎÄɲäΤۤ«¡¢²Äǽ¤Ê¸Â¤ê¤ÎºÇ¿·¾ðÊó¤ò±Ñ¹ñNICE¥¬¥¤¥É¥é¥¤¥ó¤äCochrane Review¤«¤éºÎÍѤ·¤¿´°Á´²þÄûÈǤǤ¢¤ë¡£

¤ª¼è¤ê´ó¤»(5¡Á10±Ä¶ÈÆü¤ÇȯÁ÷)
½ÐÈǼҡ§¥¢¥ë¥¿½ÐÈÇ Ãø¼Ô¡§Ê¡ÃÏ µÁÇ·²ð(ÊÔÃø)

COPD¤ÎÉÂÂÖ³µÇ°¤ÎÎò»ËŪ·Ð°Þ¤ò¿¶¤êÊÖ¤ë¤È¤È¤â¤Ë¡¤¶áǯ¤ËÁ꼡¤¤¤Ç¼Â»Ü¤µ¤ì¤¿Â絬ÌÏÎ×¾²»î¸³¤«¤éÆÀ¤é¤ì¤¿Â¿¤¯¤ÎÃ諤òÀ°Íý¤·¡¤¹ñºÝŪ¥¬¥¤¥É¥é¥¤¥ó¤ÎGOLD¤¬²Ì¤¿¤·¤Æ¤­¤¿Ìò³ä¡¤¤½¤·¤ÆÆüËܤˤª¤±¤ë¥¬¥¤¥É¥é¥¤¥ó¤¬¤É¤Î¤è¤¦¤ËÊÑÁ«¤·¤Æ¤­¤¿¤Î¤«¤òƧ¤Þ¤¨¤Ê¤¬¤é¡¤COPD¼£ÎŤΤ³¤ì¤Þ¤Ç¤Î¤¢¤æ¤ß¤ÈºÇ¿·¾ðÊó¤òÀ¹¤ê¹þ¤ó¤ÀÆâÍÆ¤È¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£

¤ª¼è¤ê´ó¤»(5¡Á10±Ä¶ÈÆü¤ÇȯÁ÷)
½ÐÈǼҡ§¥¢¥ë¥¿½ÐÈÇ Ãø¼Ô¡§¾åÅç¹ñÍø(Áí´Æ½¤)

Ëܽñ¤Ï¡¢¥ß¥ë¥Ê¥·¥×¥é¥óƳÆþ¸å10ǯ¤ò·Þ¤¨¤ë¤Ë¤¢¤¿¤ê¡¢²ó¸Ü¤Èº£¸å¤ÎŸ˾¤òÎ×¾²°å¤ÎÎ×¾²·Ð¸³¤òƧ¤Þ¤¨¤ÆÁí³ç¤·¤¿¤â¤Î¤Ç¤¢¤ë¡£¡ÖÁíÀâÊԡפǤϤ¦¤ÄɤÎÎ×¾²¤ò¤á¤°¤ëºÇ¶á¤Îư¸þ¡¢´ðÁø¦µæ¤ÎºÇÁ°Àþ¡¢¹³¤¦¤ÄÌô¼£ÎŤμºݤÈŸ˾¡¢ÌôÍýŪÆÃħ¤Þ¤Ç¤ÎºÇ¿·¤ÎÃ챤¬Ä󶡤µ¤ì¡¢¡Ö¾ÉÎãÊԡפǤϡ¢Î×¾²°å¤ÎÆü¾ïÎ×¾²¤Ç¤Î·Ð¸³¤òÄ̤¸¤¿Ãηᢹ©Éס¢Æ¶»¡¤¬45¾ÉÎã¤òÄ̤¸¤Æ¾Ò²ð¤·¤Æ¤¢¤ê¡¢SNRI¤òÍý²ò¤¹¤ë¾å¤Çɬ·È¤Î½ñ¤Ç¤¢¤ë¡£

¤ª¼è¤ê´ó¤»(5¡Á10±Ä¶ÈÆü¤ÇȯÁ÷)

Parkinson's disease 2010

 
4,200±ß¡ÊÀǹþ¡Ë
½ÐÈǼҡ§¥¢¥ë¥¿½ÐÈÇ Ãø¼Ô¡§»³Ëܸ÷Íø(ÊÔ)

¹ñÆâ³°¤Î¥Ñ¡¼¥­¥ó¥½¥óɼ£ÎŤ˷Ȥï¤ëÎ×¾²°å¤ä¸¦µæ¼Ô¤¬°ìƱ¤Ë²ñ¤·¤Æ¤½¤ÎºÇÀèü¤Î¼£ÎŤΤ¢¤êÊý¤Ë¤Ä¤¤¤ÆÆ¤µÄ¤¹¤ë¡ÖInternational Expert Meeting on the Treatment of Parkinson's Disease¡ÊIEPD¡Ë¡×¡£Ëܽñ¤Ï¡¤¤½¤ÎÂè4²ó¹Ö±é¤ò¤Þ¤È¤á¤¿¤â¤Î¤Ç¡¤11¤Î±éÂê¤ò¼ýºÜ¤·¤Æ¤¤¤Þ¤¹¡£

¤ª¼è¤ê´ó¤»(5¡Á10±Ä¶ÈÆü¤ÇȯÁ÷)

Bipolar Disorder 8

 
2,940±ß¡ÊÀǹþ¡Ë
½ÐÈǼҡ§¥¢¥ë¥¿½ÐÈÇ Ãø¼Ô¡§Bipolar Disorder¸¦µæ²ñ¡¿ÊÔ

Bipolar¡¡Disorder¤ÎÌôʪÎÅË¡¤òÄ̤¸¤ÆÎ×¾²°å¤ä¸¦µæ¼Ô¤¬Æ¤µÄ¤·°åÎŤθþ¾å¤Î¿ÊŸ¤òÌܻؤ·¤ÆÀßΩ¤µ¤ì¤¿¡ÖBipolar Disorder¸¦µæ²ñ¡×¡£¤½¤ÎÂè8²ó¹Ö±é¤ò¤Þ¤È¤á¤¿¤â¤Î¤Ç¡¤°ìÈ̱éÂê16Âê¤È¥·¥ó¥Ý¥¸¥¦¥à¹Ö±é3Âê¤ò¼ýºÜ¤·¤Æ¤¤¤Þ¤¹¡£

¤ª¼è¤ê´ó¤»(5¡Á10±Ä¶ÈÆü¤ÇȯÁ÷)

Ìä¿ÇÎϥȥ졼¥Ë¥ó¥°

 
4,200±ß¡ÊÀǹþ¡Ë
½ÐÈǼҡ§¥¢¥ë¥¿½ÐÈÇ Ãø¼Ô¡§ß·ÅÄË¡±Ñ¡¦ÅÏî´¾×°ìϺ¡¿´ÆÌõ¡¦ÊÔ

Ëܽñ¤Ï¡¢±Ñ¹ñÀº¿À°å³Ø²ñ¤ÎÀº¿À²Ê°å»ñ³Ê»î¸³¤Î¹½À®Í×ÁǤȤʤëµÒ´ÑŪÎ×¾²Ç½Îϻ¤Ë¸þ¤±¤Æ¤ÎÂкö½ñ¡ÈOSCEs in Psychiatry¡É¤ÎÌõËܤǤ¹¡£

¤ª¼è¤ê´ó¤»(5¡Á10±Ä¶ÈÆü¤ÇȯÁ÷)
½ÐÈǼҡ§¥¢¥ë¥¿½ÐÈÇ Ãø¼Ô¡§¤¢¤È¤¦¤À¤È¤·¤³¡¦¤ª¤«¤À¤è¤·¤³¡¦¤­¤¿¤à¤é¤È¤â¤³¡¿Ãø

¥Ñ¡¼¥­¥ó¥½¥óÉÂÎò30ǯ¤Î3¿Í¤Î½÷À­¤¿¤Á¤¬Ä֤ä¿Æü¾ïÀ¸³è¤ò³Ú¤Ë¡¢¤¤¤­¤¤¤­¤ÈÀ¸¤­¤ë¤¿¤á¤ÎÃηÃ269¡£

¤ª¼è¤ê´ó¤»(5¡Á10±Ä¶ÈÆü¤ÇȯÁ÷)

LAI¥Þ¥¹¥¿¡¼¥Ö¥Ã¥¯

 
4,515±ß¡ÊÀǹþ¡Ë
½ÐÈǼҡ§¥¢¥ë¥¿½ÐÈÇ Ãø¼Ô¡§Æ£°æ¹¯ÃË¡¿´Æ½¤

Ëܽñ¤Ï¡¢Âè2À¤Âå¹³Àº¿ÀÉÂÌô¤Î¥Ç¥ÝºÞ(long-acting injection¡§LAI)¤Ë¤Ä¤¤¤Æ¡¢¼ÂÍÑŪ¡¦Êñ³çŪÃ챤¬½¬ÆÀ¤Ç¤­¤ë¤è¤¦¤Ë62¹àÌܤÎFAQ¤È¤·¤Æ¤Þ¤È¤á¤¿¤â¤Î¤Ç¤¹¡£°ìÄê¤ÎÎ×¾²·Ð¸³¤¬¤¢¤ëÀº¿À²Ê°å¤Ï¤â¤È¤è¤ê¡¢Àº¿À²Ê¤òÌܻؤ¹¸¦½¤°å¤äÀº¿À²ÊÀìÌçÌôºÞ»Õ¡¢´Ç¸î»Õ¤Ê¤É¤Ë¤â½½Ê¬Íý²ò¤Ç¤­¡¢ÌòΩ¤ÄÆâÍÆ¤È¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£

¤ª¼è¤ê´ó¤»(5¡Á10±Ä¶ÈÆü¤ÇȯÁ÷)
¥Á¥§¥Ã¥¯¤·¤¿¾¦Éʤ¬¤¢¤ë¾ì¹ç¤Ï¼¡¤Î²èÌ̤ذܤëÁ°¤Ë¡¢¥«¡¼¥È¤Ëɬ¤ºÆþ¤ì¤Æ¤¯¤À¤µ¤¤¡£
¥Á¥§¥Ã¥¯¤·¤¿¾¦Éʤò¥«¡¼¥È¤ËÆþ¤ì¤ë

½ÐÈǼҰìÍ÷¤ØÌá¤ë